- Nykaa’s net income for the first quarter was 96.4 million rupees.
- This is a significant increase from 33 million rupees in the same period last year.
- However, it fell short of the estimated net income of 194 million rupees.
- Revenue rose to 17.5 billion rupees, marking a 23% increase year-over-year.
- Despite the revenue growth, it still missed the estimate of 17.63 billion rupees.
- Total costs for the quarter were 17.3 billion rupees, up by 22% compared to the previous year.
- Other income amounted to 73.3 million rupees, showing a 9.1% year-over-year increase.
- Shares of Nykaa fell by 3.8%, closing at 187.26 rupees.
- A total of 8.56 million shares were traded during this period.
- Analyst ratings: 14 buys, 5 holds, and 4 sells.
A look at FSN E-Commerce Ventures (Nykaa) Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 1 | |
| Growth | 5 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 2.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
FSN E-Commerce Ventures (Nykaa) has been assigned Smartkarma Smart Scores across various factors, indicating its long-term outlook in the market. With a strong Growth score of 5, the company is poised for significant expansion and development in the e-commerce sector. This suggests a promising future for Nykaa in terms of scaling its beauty and personal care offerings.
While the Value score of 2 suggests moderate performance in terms of valuation, Nykaa receives a Resilience score of 3, indicating a level of stability that may help weather market uncertainties. With a Momentum score of 3, Nykaa demonstrates ongoing market interest and potential for future growth. Overall, Nykaa displays strengths in growth potential and market momentum, positioning it favorably for long-term success in the e-commerce industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
